PuSH - Publication Server of Helmholtz Zentrum München

Unbiased prediction and feature selection in high-dimensional survival regression.

J. Comput. Biol. 23, 279-290 (2016)
Postprint DOI PMC
Open Access Green
as soon as is submitted to ZB.
With widespread availability of omics profiling techniques, the analysis and interpretation of high-dimensional omics data, for example, for biomarkers, is becoming an increasingly important part of clinical medicine because such datasets constitute a promising resource for predicting survival outcomes. However, early experience has shown that biomarkers often generalize poorly. Thus, it is crucial that models are not overfitted and give accurate results with new data. In addition, reliable detection of multivariate biomarkers with high predictive power (feature selection) is of particular interest in clinical settings. We present an approach that addresses both aspects in high-dimensional survival models. Within a nested cross-validation (CV), we fit a survival model, evaluate a dataset in an unbiased fashion, and select features with the best predictive power by applying a weighted combination of CV runs. We evaluate our approach using simulated toy data, as well as three breast cancer datasets, to predict the survival of breast cancer patients after treatment. In all datasets, we achieve more reliable estimation of predictive power for unseen cases and better predictive performance compared to the standard CoxLasso model. Taken together, we present a comprehensive and flexible framework for survival models, including performance estimation, final feature selection, and final model construction. The proposed algorithm is implemented in an open source R package (SurvRank) available on CRAN.
Altmetric
Additional Metrics?
Tags
Icb_AtheroMed Icb_Integrament Icb_metabo Icb_MIMOmics
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Feature Selection ; High-dimensional Survival Regression ; Repeated Nested Cross Validation; Penalized Cox Regression; Breast-cancer Patients; Expression; Model; Lasso; Population; Signature; Risk
Reviewing status